Taysha Gene Therapies Stock Market Value
| TSHA Stock | USD 3.24 0.24 8.00% |
| Symbol | Taysha |
Taysha Gene Therapies Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Taysha Gene. If investors know Taysha will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Taysha Gene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.63 | Revenue Per Share 0.042 | Quarterly Revenue Growth (0.62) | Return On Assets (0.27) | Return On Equity (1.15) |
The market value of Taysha Gene Therapies is measured differently than its book value, which is the value of Taysha that is recorded on the company's balance sheet. Investors also form their own opinion of Taysha Gene's value that differs from its market value or its book value, called intrinsic value, which is Taysha Gene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Taysha Gene's market value can be influenced by many factors that don't directly affect Taysha Gene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Taysha Gene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Taysha Gene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Taysha Gene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Taysha Gene 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Taysha Gene's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Taysha Gene.
| 12/08/2023 |
| 12/02/2024 |
If you would invest 0.00 in Taysha Gene on December 8, 2023 and sell it all today you would earn a total of 0.00 from holding Taysha Gene Therapies or generate 0.0% return on investment in Taysha Gene over 360 days. Taysha Gene is related to or competes with Biomea Fusion, Stoke Therapeutics, Akero Therapeutics, Gossamer Bio, X4 Pharmaceuticals, Inozyme Pharma, and Terns Pharmaceuticals. Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-ba... More
Taysha Gene Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Taysha Gene's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Taysha Gene Therapies upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.19 | |||
| Information Ratio | 0.1009 | |||
| Maximum Drawdown | 55.88 | |||
| Value At Risk | (9.25) | |||
| Potential Upside | 12.25 |
Taysha Gene Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Taysha Gene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Taysha Gene's standard deviation. In reality, there are many statistical measures that can use Taysha Gene historical prices to predict the future Taysha Gene's volatility.| Risk Adjusted Performance | 0.0994 | |||
| Jensen Alpha | 0.6414 | |||
| Total Risk Alpha | (0.40) | |||
| Sortino Ratio | 0.1541 | |||
| Treynor Ratio | 0.4129 |
Taysha Gene Therapies Backtested Returns
Taysha Gene appears to be very risky, given 3 months investment horizon. Taysha Gene Therapies owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.12, which indicates the firm had a 0.12% return per unit of risk over the last 3 months. By inspecting Taysha Gene's technical indicators, you can evaluate if the expected return of 0.98% is justified by implied risk. Please review Taysha Gene's Coefficient Of Variation of 845.84, semi deviation of 4.58, and Risk Adjusted Performance of 0.0994 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Taysha Gene holds a performance score of 9. The entity has a beta of 2.25, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Taysha Gene will likely underperform. Please check Taysha Gene's downside variance, daily balance of power, period momentum indicator, as well as the relationship between the skewness and day typical price , to make a quick decision on whether Taysha Gene's existing price patterns will revert.
Auto-correlation | -0.32 |
Poor reverse predictability
Taysha Gene Therapies has poor reverse predictability. Overlapping area represents the amount of predictability between Taysha Gene time series from 8th of December 2023 to 5th of June 2024 and 5th of June 2024 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Taysha Gene Therapies price movement. The serial correlation of -0.32 indicates that nearly 32.0% of current Taysha Gene price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.32 | |
| Spearman Rank Test | -0.43 | |
| Residual Average | 0.0 | |
| Price Variance | 0.3 |
Taysha Gene Therapies lagged returns against current returns
Autocorrelation, which is Taysha Gene stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Taysha Gene's stock expected returns. We can calculate the autocorrelation of Taysha Gene returns to help us make a trade decision. For example, suppose you find that Taysha Gene has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Taysha Gene regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Taysha Gene stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Taysha Gene stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Taysha Gene stock over time.
Current vs Lagged Prices |
| Timeline |
Taysha Gene Lagged Returns
When evaluating Taysha Gene's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Taysha Gene stock have on its future price. Taysha Gene autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Taysha Gene autocorrelation shows the relationship between Taysha Gene stock current value and its past values and can show if there is a momentum factor associated with investing in Taysha Gene Therapies.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Taysha Gene Therapies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Taysha Gene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Taysha Gene Therapies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Taysha Gene Therapies Stock:Check out Taysha Gene Correlation, Taysha Gene Volatility and Taysha Gene Alpha and Beta module to complement your research on Taysha Gene. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Taysha Gene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.